United Therapeutics (UTHR) Tops Q3 EPS by 16c
Get inside Wall Street with StreetInsider Premium. Claim your 2-week free trial here.
United Therapeutics (NASDAQ: UTHR) reported Q3 EPS of $3.50, $0.16 better than the analyst estimate of $3.34. Revenue for the quarter came in at $408.2 million versus the consensus estimate of $402.35 million.
For earnings history and earnings-related data on United Therapeutics (UTHR) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Steelcase (SCS) Reports Preliminary Q3 EPS In-Line with Views, Revs Light
- Restoration Hardware (RH) Tops Q3 EPS by 4c; Guides Well Below the Street
- Dominion Diamond (DDC) Reports Q3 Loss of $0.34/Share
Create E-mail Alert Related CategoriesEarnings
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!